Skip to main navigation
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Our Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Full-Spectrum Blog
  • Contact
logo
  • Full-Spectrum Blog
  • Contact
  • About
    • Our Mission
    • Core Values
    • Leadership
    • Partners
  • CRISPR/Cas9
    • What’s CRISPR/Cas9?
    • How CRISPR/Cas9 Works
    • Types of Edits
    • Glossary
  • Programs & Pipelines
    • Full-Spectrum Approach
    • Pipeline
    • In Vivo Therapies
    • Ex Vivo Therapies
  • Patients & Families
    • Our Commitment
    • Clinical Trials
    • Community Perspectives & Resources
    • Expanded Access Policy
  • Healthcare Professionals
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
Investors & Media

Events & Presentations

Investor Relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Deck
  • Events & Presentations
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Stock Info
  • Analyst Coverage
  • Investor Resources

Events and Presentations

  • Upcoming Events
  • Past Events
  • Presentations
  • ESG Report
All Past Events
2022
2021
2020
Nov 16, 2020 9:45 AM EST
Intellia Therapeutics, Inc. at the Barclays Gene Editing & Gene Therapy Summit
Click Here for Webcast
Nov 11, 2020 2:45 PM EST
Intellia Therapeutics, Inc. at the Credit Suisse 29th Annual Virtual Healthcare Conference
Click Here for Webcast
Nov 5, 2020 8:00 AM EST
Intellia Therapeutics Third Quarter 2020 Earnings Conference Call

US dial-in: 1-877-317-6789
International dial-in: 1-412-317-6789
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Oct 5, 2020 9:00 AM EDT
Intellia Therapeutics, Inc. at Chardan’s Virtual 4th Annual Genetic Medicines Conference
Click Here for Webcast
Sep 9, 2020 10:50 AM EDT
Intellia Therapeutics, Inc. at the Baird’s 2020 Virtual Global Healthcare Conference
Click Here for Webcast
Aug 11, 2020 3:30 PM EDT
Intellia Therapeutics, Inc. at the Wedbush PacGrow Healthcare Conference
Click Here for Webcast
Aug 6, 2020 8:00 AM EDT
Intellia Therapeutics Second Quarter 2020 Earnings Conference Call

US dial-in: 1-877-317-6789
International dial-in: 1-412-317-6789
All participants should ask to be connected to the Intellia Therapeutics conference call.

Click Here for Webcast Replay
Jun 18, 2020 9:00 AM EDT
Intellia Therapeutics 2020 Annual Meeting of Shareholders

Location:

Virtual meeting via internet
Contact IR Contact IR
Email Alerts
RSS Feeds
RSS Feeds
Print Page

Footer Links

  • Cookie Policy
  • Terms of Use
  • Privacy Policy

© Intellia Therapeutics, Inc. 2022

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.